Thrombosis in Vascular Access for Hemodialysis: Mechanisms, Prevention, and ManagementAuthor(s): Navneeth Singh
Thrombosis in vascular access represents a significant challenge in the realm of hemodialysis, often compromising the efficacy and longevity of access sites critical for this life-sustaining therapy. This article, “Thrombosis in Vascular Access for Hemodialysis: Mechanisms, Prevention, and Management,” delves into the intricate mechanisms underpinning thrombosis in hemodialysis access, emphasizing its multifactorial nature. Thrombosis can occur within arteriovenous fistulas, grafts, and catheters, each presenting distinct etiological factors. The article explores evidence-based strategies for thrombosis prevention, encompassing anticoagulation regimens, antiplatelet therapies, and vascular access surveillance. Furthermore, it delves into management approaches when thrombosis does occur, including thrombectomy, angioplasty, and surgical revision. Understanding the nuances of thrombosis in vascular access is pivotal in enhancing patient outcomes, preserving access patency, and ensuring the continued delivery of hemodialysis therapy to those who depend on it. This article serves as a comprehensive resource for healthcare providers, offering insights into the complex landscape of thrombosis in hemodialysis access and strategies to mitigate its impact on patient care and well-being.